article thumbnail

Bone Void Filler Cerament G: The Combination Product by BONESUPPORT Gets Market Authorization from the FDA

XTalks

Ceramanet G, a bone void filler with the antibiotic gentamicin, fills bone voids and immediately begins bone healing with protection. Cerament G is a bone void filler treatment that can fill the gaps in the affected bones and simultaneously deliver the antibiotic gentamicin to reduce the risk of reinfection. mg/mL of cerament paste.

Filler 98
article thumbnail

SkinVive by Juvéderm: The New Dermal Filler Coming to the US

XTalks

Allergan Aesthetics, an AbbVie company renowned for its development of leading aesthetics brands and products, recently announced the US Food and Drug Administration (FDA) approved their ground-breaking hyaluronic acid product, SkinVive by Juvéderm, for achieving remarkable skin smoothness.

Filler 92
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

BENEO presents galenIQ for highly flowable and stable sachet powders

Pharma Mirror

BENEO’s filler-binder galenIQ™ 721 meets this demand and helps formulators to develop more convenient dosage forms. Sachets are a popular pharmaceutical and nutraceutical packaging format for consumers and manufacturers alike.

Filler 130
article thumbnail

UBCO researchers find a new use for waste

Scienmag

Pulp mill waste hits the road instead of the landfill Credit: UBCO Waste materials from the pulp and paper industry have long been seen as possible fillers for building products like cement, but for years these materials have ended up in the landfill. Now, researchers at UBC Okanagan are developing guidelines to use this waste […].

Filler 98
article thumbnail

Galderma Announces Exclusive Agreement With Sofregen to Develop the Next Generation of Biostimulator Fillers Using Silk-Based Technology

BioTech 365

Galderma Announces Exclusive Agreement With Sofregen to Develop the Next Generation of Biostimulator Fillers Using Silk-Based Technology Galderma Announces Exclusive Agreement With Sofregen to Develop the Next Generation of Biostimulator Fillers Using Silk-Based Technology Agreement adds cutting-edge innovation to Galderma’s … Continue reading (..)

Filler 40
article thumbnail

BONESUPPORT CEO Emil Billbäck Shares Insights About Cerament G, the New Bone Void Filler Launching in the US

XTalks

Individuals at risk for developing osteomyelitis include those with a weak immune system, traumatic injury or wound, pressure injuries, artificial joints (like hip replacements) or metal implants in bone, blood infection and diabetes. due to a traffic accident), the more likely it is that an infection will develop.

Filler 98
article thumbnail

EU probes low platelet safety issue with COVID-19 shots

pharmaphorum

There has also been a signal of localised swelling related to dermal fillers with the Pfizer/BioNTech shot, which has the brand name Comirnaty in Europe, and will be investigated separately by the PRAC. Existing guidance says that any person developing such a reaction after the first dose of the vaccine should not be given a second dose.

Vaccine 145